Epicor Ultrasound Cardiac Ablation Device Draws $200 Mil. From St. Jude
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical will roll out its High Intensity Focused Ultrasound (HIFU) ablation technology in July with training and market development programs aimed at select cardiac care centers
You may also be interested in...
St. Jude Augments AF Division With $47 Mil. Irvine Biomedical Purchase
St. Jude will evaluate whether to pursue an atrial fibrillation indication for Irvine Biomedical, Inc.'s Therapy, Dual 8 and Cooled-Tip ablation catheters
St. Jude Augments AF Division With $47 Mil. Irvine Biomedical Purchase
St. Jude will evaluate whether to pursue an atrial fibrillation indication for Irvine Biomedical, Inc.'s Therapy, Dual 8 and Cooled-Tip ablation catheters
St. Jude Daig Division Splits To Emphasize Vascular Closure, AF Devices
Newly appointed president of St. Jude Medical's cardiology division Paul Buckman will work to retain AngioSeal's number-one position in the U.S. vascular closure device market as newcomer Abbott Labs tries to gain ground